Fidelity Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-118,794
| Closed | -$18M | – | 5728 |
|
2022
Q3 | $18M | Buy |
118,794
+1,286
| +1% | +$194K | ﹤0.01% | 1648 |
|
2022
Q2 | $17.1M | Sell |
117,508
-1,434,343
| -92% | -$209M | ﹤0.01% | 1711 |
|
2022
Q1 | $184M | Buy |
1,551,851
+41,001
| +3% | +$4.86M | 0.01% | 819 |
|
2021
Q4 | $208M | Buy |
1,510,850
+229,600
| +18% | +$31.6M | 0.02% | 793 |
|
2021
Q3 | $178M | Buy |
1,281,250
+141,076
| +12% | +$19.6M | 0.01% | 857 |
|
2021
Q2 | $111M | Buy |
1,140,174
+21,950
| +2% | +$2.13M | 0.01% | 1081 |
|
2021
Q1 | $76.4M | Sell |
1,118,224
-235,913
| -17% | -$16.1M | 0.01% | 1191 |
|
2020
Q4 | $116M | Sell |
1,354,137
-25,880
| -2% | -$2.22M | 0.01% | 961 |
|
2020
Q3 | $89.7M | Buy |
1,380,017
+27,603
| +2% | +$1.79M | 0.01% | 962 |
|
2020
Q2 | $98.9M | Buy |
1,352,414
+562,071
| +71% | +$41.1M | 0.01% | 878 |
|
2020
Q1 | $26.9M | Buy |
790,343
+90,064
| +13% | +$3.06M | ﹤0.01% | 1287 |
|
2019
Q4 | $38.1M | Hold |
700,279
| – | – | ﹤0.01% | 1328 |
|
2019
Q3 | $29.2M | Buy |
700,279
+360,916
| +106% | +$15.1M | ﹤0.01% | 1419 |
|
2019
Q2 | $14.9M | Sell |
339,363
-117,004
| -26% | -$5.12M | ﹤0.01% | 1737 |
|
2019
Q1 | $23.5M | Sell |
456,367
-384,865
| -46% | -$19.8M | ﹤0.01% | 1533 |
|
2018
Q4 | $31.1M | Sell |
841,232
-57,600
| -6% | -$2.13M | ﹤0.01% | 1375 |
|
2018
Q3 | $33.8M | Sell |
898,832
-455,232
| -34% | -$17.1M | ﹤0.01% | 1466 |
|
2018
Q2 | $53.5M | Buy |
1,354,064
+846,141
| +167% | +$33.4M | 0.01% | 1245 |
|
2018
Q1 | $13.1M | Sell |
507,923
-527,600
| -51% | -$13.6M | ﹤0.01% | 1873 |
|
2017
Q4 | $27.9M | Hold |
1,035,523
| – | – | ﹤0.01% | 1562 |
|
2017
Q3 | $38.7M | Hold |
1,035,523
| – | – | ﹤0.01% | 1421 |
|
2017
Q2 | $25.9M | Buy |
+1,035,523
| New | +$25.9M | ﹤0.01% | 1574 |
|